406 related articles for article (PubMed ID: 35316296)
41. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
42. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
43. Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.
Maldonado MDM; Schlom J; Hamilton DH
Cancer Immunol Immunother; 2023 Oct; 72(10):3349-3362. PubMed ID: 37505292
[TBL] [Abstract][Full Text] [Related]
44. Macrophage colony-stimulating factor increases hepatic macrophage content, liver growth, and lipid accumulation in neonatal rats.
Pridans C; Sauter KA; Irvine KM; Davis GM; Lefevre L; Raper A; Rojo R; Nirmal AJ; Beard P; Cheeseman M; Hume DA
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G388-G398. PubMed ID: 29351395
[TBL] [Abstract][Full Text] [Related]
45. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
[TBL] [Abstract][Full Text] [Related]
46. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
Liu X; Tang R; Xu J; Tan Z; Liang C; Meng Q; Lei Y; Hua J; Zhang Y; Liu J; Zhang B; Wang W; Yu X; Shi S
Gut; 2023 Nov; 72(12):2329-2343. PubMed ID: 37541772
[TBL] [Abstract][Full Text] [Related]
47. Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer.
Grauers Wiktorin H; Aydin E; Kiffin R; Vilhav C; Bourghardt Fagman J; Kaya M; Paul S; Westman B; Bratlie SO; Naredi P; Hellstrand K; Martner A
Cancer Res Commun; 2024 Apr; 4(4):1135-1149. PubMed ID: 38598844
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
Schrezenmeier H; Thomé SD; Tewald F; Fleischer B; Raghavachar A
Exp Hematol; 1993 Feb; 21(2):358-65. PubMed ID: 8425573
[TBL] [Abstract][Full Text] [Related]
49. TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors.
Li G; Abediankenari S; Kim YJ; Campbell TB; Ito S; Graham-Evans B; Cooper S; Broxmeyer HE
Blood; 2007 Oct; 110(8):2872-9. PubMed ID: 17585053
[TBL] [Abstract][Full Text] [Related]
50. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
51. Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptor.
Tweardy DJ; Morel PA; Mott PL; Glazer EW; Zeh HJ; Sakurai M
Blood; 1992 Jul; 80(2):359-66. PubMed ID: 1378315
[TBL] [Abstract][Full Text] [Related]
52. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
[TBL] [Abstract][Full Text] [Related]
53.
Hawley CA; Rojo R; Raper A; Sauter KA; Lisowski ZM; Grabert K; Bain CC; Davis GM; Louwe PA; Ostrowski MC; Hume DA; Pridans C; Jenkins SJ
J Immunol; 2018 Mar; 200(6):2209-2223. PubMed ID: 29440354
[TBL] [Abstract][Full Text] [Related]
54. CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.
Xu J; Escamilla J; Mok S; David J; Priceman S; West B; Bollag G; McBride W; Wu L
Cancer Res; 2013 May; 73(9):2782-94. PubMed ID: 23418320
[TBL] [Abstract][Full Text] [Related]
55. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870
[TBL] [Abstract][Full Text] [Related]
56. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.
Iida-Norita R; Kawamura M; Suzuki Y; Hamada S; Masamune A; Furukawa T; Sato Y
Cancer Sci; 2019 Jul; 110(7):2296-2308. PubMed ID: 31074083
[TBL] [Abstract][Full Text] [Related]
57. CSF1R
Candido JB; Morton JP; Bailey P; Campbell AD; Karim SA; Jamieson T; Lapienyte L; Gopinathan A; Clark W; McGhee EJ; Wang J; Escorcio-Correia M; Zollinger R; Roshani R; Drew L; Rishi L; Arkell R; Evans TRJ; Nixon C; Jodrell DI; Wilkinson RW; Biankin AV; Barry ST; Balkwill FR; Sansom OJ
Cell Rep; 2018 May; 23(5):1448-1460. PubMed ID: 29719257
[TBL] [Abstract][Full Text] [Related]
58. Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.
Basso D; Fogar P; Falconi M; Fadi E; Sperti C; Frasson C; Greco E; Tamburrino D; Teolato S; Moz S; Bozzato D; Pelloso M; Padoan A; De Franchis G; Gnatta E; Facco M; Zambon CF; Navaglia F; Pasquali C; Basso G; Semenzato G; Pedrazzoli S; Pederzoli P; Plebani M
PLoS One; 2013; 8(1):e54824. PubMed ID: 23359812
[TBL] [Abstract][Full Text] [Related]
59. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line.
Sato T; Muramatsu T; Tanabe M; Inazawa J
Cancer Sci; 2018 Nov; 109(11):3623-3633. PubMed ID: 30156359
[TBL] [Abstract][Full Text] [Related]
60. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
Blondy T; d'Almeida SM; Briolay T; Tabiasco J; Meiller C; Chéné AL; Cellerin L; Deshayes S; Delneste Y; Fonteneau JF; Boisgerault N; Bennouna J; Grégoire M; Jean D; Blanquart C
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
